Open AccessAdjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon Cancer
Author(s) -
Katherine L. Kahn
Publication year - 2010
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2010.272
Subject(s) - medicine , regimen , adverse effect , oxaliplatin , colorectal cancer , chemotherapy regimen , veterans affairs , population , cancer , chemotherapy , poisson regression , confidence interval , surgery , environmental health
Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage III colon cancer. However, older patients are less likely to receive this therapy than younger patients, perhaps because of concern about adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom